CLINICAL_TRIALS ClinicalTrials.gov record update

ENCORE: Multicenter ProspectivE Registry of Sequential ANtibody Drug COnjugates (ADCs) in HER2 Negative Metastatic BREast Cancer (MBC)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06774027
Title field or adapter rule: {'original_value': 'ENCORE: Multicenter ProspectivE Registry of Sequential ANtibody Drug COnjugates (ADCs) in HER2 Negative Metastatic BREast Cancer (MBC)', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At: 2026-10-31T23:27:30.637078+00:00
Published At: 2026-10-16T00:00:00+00:00
Record Updated At: 2026-10-16
Source Retrieved At: 2026-10-31T22:18:22.973355+00:00
Timestamp Basis: ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation: ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions: ["HER2-negative Breast Cancer", "HER2 Negative Breast Carcinoma", "Metastatic Breast Cancer", "HR+ HER2 Breast Cancer", "Metastatic Triple Negative Breast Cancers", "Metastatic Triple-Negative Breast Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct: {"date": "2026-10-16", "type": "ACTUAL"}
protocolSection.identificationModule.nctId: "NCT06774027"
protocolSection.identificationModule.officialTitle: "ENCORE: Multicenter ProspectivE Registry of Sequential ANtibody Drug COnjugates (ADCs) in HER2 Negative Metastatic BREast Cancer (MBC)"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: null
protocolSection.statusModule.resultsFirstPostDateStruct: null

Study condition terms

Interventions recorded in this study

{'armGroupLabels': ['Cohort 1: HR+/HER2- mBC participants enrolled before first line ADC (ADC1))', 'Cohort 2: Metastatic Triple Negative Breast Cancer (mTNBC) participants enrolled before ADC1', 'Cohort 3: HR+/HER2- mBC Participants enrolled before second line ADC (ADC2))', 'Cohort 4: mTNBC participants enrolled before ADC2'], 'description': 'Blood specimens will be collected during regular clinical visits for correlative and exploratory analysis', 'name': 'Specimen collection', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Cohort 1: HR+/HER2- mBC participants enrolled before first line ADC (ADC1))', 'Cohort 2: Metastatic Triple Negative Breast Cancer (mTNBC) participants enrolled before ADC1', 'Cohort 3: HR+/HER2- mBC Participants enrolled before second line ADC (ADC2))', 'Cohort 4: mTNBC participants enrolled before ADC2'], 'description': 'ADC given under usual care for the treatment of cancer', 'name': 'Non-Investigational Antibody-Drug Conjugates (ADC)', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Cohort 1: HR+/HER2- mBC participants enrolled before first line ADC (ADC1))', 'Cohort 2: Metastatic Triple Negative Breast Cancer (mTNBC) participants enrolled before ADC1', 'Cohort 3: HR+/HER2- mBC Participants enrolled before second line ADC (ADC2))', 'Cohort 4: mTNBC participants enrolled before ADC2'], 'description': 'Prospective and retrospective medical chart reviews will be conducted to obtain data for analysis.', 'name': 'Medical Record Review', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.